Clepio is a startup company aiming at bringing 3D histology and spatial biology a reality.
Our vision: 2D analysis of biological tissue leads to severe sampling biases, reducing the reliability of information extracted from histology and spatial biology methods. 3D analysis gets rid of all this limitation, enabling a quantum leap in biology and medicine.
Our mission: bring to the market a reliable and scalable solution for 3D analysis of biological tissue, compliant with IVDR and FDA regulations. With our proprietary technology we can finally enable the transition towards a fully-3D histology and spatial biology.
Social media
Areas of activity
Type of Cooperation
Research collaborationClinical validationConsortium partners
Our goal is to validate the prognostic and predictive accuracy of histological biomarkers in 3D, exploiting our scalable 3D histology solution. This approach will solve the sampling bias inherent in state-of-the art 2D histological approaches